Tango Therapeutics logo

Tango Therapeutics Share Price (NASDAQ: TNGX)

$6.71

-0.11

(-1.61%)

Last updated on

Check the interactive Tango Therapeutics Stock chart to analyse performance

Tango Therapeutics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$6.66
    Today's High:$6.85

    Day's Volatility :2.77%

  • 52 Weeks Low:$1.03
    52 Weeks High:$11.92

    52 Weeks Volatility :91.36%

Tango Therapeutics Stock Returns

PeriodTango Therapeutics IncIndex (Russel 2000)
3 Months
164.57%
0.0%
6 Months
253.68%
0.0%
1 Year
-38.52%
0.0%
3 Years
57.75%
-4.7%

Tango Therapeutics Inc Key Stats

Check Tango Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$6.82
Open
$6.84
Today's High
$6.85
Today's Low
$6.66
Market Capitalization
$767.7M
Today's Volume
$721.3K
52 Week High
$11.92
52 Week Low
$1.03
Revenue TTM
$24.3M
EBITDA
$-154.8M
Earnings Per Share (EPS)
$-1.32
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-76.09%

Stock Returns calculator for Tango Therapeutics Stock including INR - Dollar returns

The Tango Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Tango Therapeutics investment value today

Current value as on today

₹66,675

Returns

₹33,325

(-33.33%)

Returns from Tango Therapeutics Stock

₹38,609 (-38.61%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Tango Therapeutics Stock

0%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Tango Therapeutics Stock from India on INDmoney has increased by 0% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Tango Therapeutics Inc

  • Name

    Holdings %

  • TRV GP IV, LLC

    15.15%

  • TCG Crossover Management, LLC

    9.65%

  • EcoR1 Capital, LLC

    9.55%

  • Boxer Capital Management, LLC

    9.33%

  • Woodline Partners LP

    5.42%

  • Nextech Invest, Ltd.

    4.97%

Analyst Recommendation on Tango Therapeutics Stock

Rating
Trend

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 14 Wall street analysts offering stock ratings for Tango Therapeutics(by analysts ranked 0 to 5 stars)

Tango Therapeutics Share Price Target

What analysts predicted

Upside of 62.07%

Target:

$10.88

Current:

$6.71

Tango Therapeutics share price target is $10.88, a slight Upside of 62.07% compared to current price of $6.71 as per analysts' prediction.

Tango Therapeutics Stock Insights

  • Price Movement

    In the last 3 months, TNGX stock has moved up by 202.7%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 5.39M → 3.18M (in $), with an average decrease of 41.0% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -39.87M → -38.85M (in $), with an average increase of 2.6% per quarter
  • TNGX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 113.1%
  • TNGX vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 50.7%
  • Price to Sales

    ForTNGX every $1 of sales, investors are willing to pay $30.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Tango Therapeutics Inc Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$42.1M
↑ 15.17%
Net Income
$-130.3M
↑ 28.07%
Net Profit Margin
-309.73%
↓ 31.19%

Tango Therapeutics Technicals Summary

Sell

Neutral

Buy

Tango Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Tango Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Tango Therapeutics Inc logo
2.91%
253.68%
-38.52%
57.75%
-32.73%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Tango Therapeutics Inc

Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need. The company develops methylthioadenosine -cooperative protein arginine methyltransferase 5 (PRMT5) inhibitors, including TNG462, which is in Phase 1/2 clinical trial for treating pancreatic and lung cancer; and TNG456, a brain-penetrant PRMT5 inhibitor for the treatment of glioblastoma. It is developing TNG260, a co-repressor of repressor element-1 silencing transcription inhibitor to reverse the immune evasion effect of serine-threonine kinase 11 loss-of-function mutations for treating lung cancer. The company was founded in 2017 and is headquartered in Boston, Massachusetts.
Organization
Tango Therapeutics
Employees
155
CEO
Dr. Barbara L. Weber M.D.
Industry
Miscellaneous

Key Management of Tango Therapeutics Inc

NameTitle
Dr. Barbara L. Weber M.D.
President, CEO & Director
Ms. Daniella Beckman CPA
Chief Financial Officer
Mr. Douglas J. Barry Esq., J.D.
Chief Legal Officer, Chief Compliance Officer & Corporate Secretary
Dr. Adam S. Crystal M.D., Ph.D.
President of Research & Development
Prof. Alan Ashworth FRS, Ph.D.
Founder & Member of Scientific Advisory Board
Dr. William G. Kaelin Jr., M.D.
Founder & Member of Scientific Advisory Board
Dr. Antoni Ribas M.D., Ph.D.
Founder & Member of Scientific Advisory Board
Dr. Michael Palmieri Ph.D.
Head of Technical Operations
Mr. Jannik N. Andersen Ph.D.
Chief Scientific Officer
Ms. Elizabeth Pingpank Hickin
VP of IR & Corporate Communications

Important FAQs about investing in TNGX Stock from India :

What is Tango Therapeutics share price today?

Tango Therapeutics share price today is $6.71 as on at the close of the market. Tango Therapeutics share today touched a day high of $6.85 and a low of $6.66.

What is the 52 week high and 52 week low for Tango Therapeutics share?

Tango Therapeutics share touched a 52 week high of $11.92 and a 52 week low of $1.03. Tango Therapeutics stock price today i.e. is closed at $6.71, lower by 43.71% versus the 52 week high.

How to invest in Tango Therapeutics Stock (TNGX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Tango Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tango Therapeutics Shares that will get you 0.2235 shares as per Tango Therapeutics share price of $6.71 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Tango Therapeutics Stock (TNGX) from India?

Indian investors can start investing in Tango Therapeutics (TNGX) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Tango Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Tango Therapeutics share’s latest price of $6.71 as on August 30, 2025 at 1:29 am IST, you will get 1.4903 shares of Tango Therapeutics. Learn more about fractional shares .

What are the returns that Tango Therapeutics has given to Indian investors in the last 5 years?

Tango Therapeutics stock has given -32.73% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?